Steve Kafka - Profile and Investment Details

Investor Profile

Steve Kafka is a Venture Capital, Private Equity Firm, Investor based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as Miroculus, Auris Health, Dialpad, XOKind, Ciitizen, Relay Therapeutics, Alector, Cue, Freenome, Meatable, MedCrypt, WithMe Health, Primer, Aspen Neuroscience, EmbarkKobalt, Fulcrum Therapeutics, Thrive Earlier Detection, Forrester Research, Legacy, Coinbase, Glympse Bio, EQRx, BloomAPI, Evidation Health, Autobahn Therapeutics, Cradle Genomics, Octave Bioscience, Sema4, Culture Biosciences, Lime, Neocis, Celularity, Vineti, Metromile, Teckro, . Over time, Steve Kafka has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Steve Kafka is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Genetics, Wellness, Women Founded, Enterprise Software, Consumer Goods, Artificial Intelligence (AI), Robotics, Information Technology (IT), Cloud Computing, Software, Manufacturing, Biotechnology, Hispanic / Latinx Founded, Electronic Health Records (EHR), Genomics, Health and Hospital Services, Productivity Software, Food and Beverage, Clinical Trials, Employee Benefits, Home Care, Insurance, Health Diagnostics, Innovation Management, Digital Health, Medical, Therapeutics, Media and Entertainment, Machine Learning, Pharmaceuticals may find it worthwhile to explore potential connections with Steve Kafka, as their portfolio suggests a familiarity and interest in this area.

Understanding Steve Kafka’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.